Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII-Tubulin Expression as a Predictive Marker

BACKGROUND. This randomized phase II trial was designed to compare the rate of pathologic complete response (pCR) induced by neoadjuvant cyclophosphamide plus doxorubicin (AC) followed by ixabepilone or paclitaxel in women with early stage breast cancer (BC). Expression of βIII-tubulin as a predicti...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Saura, Cristina, Tseng, Ling-Ming, Chan, Stephen, Chacko, Raju T., Campone, Mario, Manikhas, Alexy, Nag, Shona M., Leichman, Cynthia G., Dasappa, Lokanatha, Fasching, Peter A., Hurtado de Mendoza, Fernando, Symmans, W. Fraser, Liu, David, Mukhopadhyay, Pralay, Horak, Christine, Xing, Guan, Pusztai, Lajos
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: AlphaMed Press 2013
Gaiak:
Academia-Pharma Intersect: Breast Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3720631/
https://ncbi.nlm.nih.gov/pubmed/23853246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0075
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak